Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease

Journal of Chromatography B: Biomedical Applications

Volumn 702, Issue 1-2, 1997, Pages 131-141

  Van der Geest, R ^a   Kruger, P ^a   Gubbens Stibbe, J M ^a   Van Laar, T ^b   Bodde, H E ^a   Danhof, M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apocodeine; Apomorphine; Isoapocodeine

Indexed keywords

ACETONITRILE; APOCODEINE; APOMORPHINE; BETA GLUCURONIDASE; GLUCURONIDE; ISOAPOCODEINE; SULFATASE; SULFATE; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CONJUGATE; CONTROLLED STUDY; DEGRADATION; DRUG BLOOD LEVEL; DRUG ISOLATION; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; INTRAVENOUS DRUG ADMINISTRATION; ION PAIR CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; NUCLEAR MAGNETIC RESONANCE; PARKINSON DISEASE; PLASMA; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY; URINE;

ACETIC ACID; ANTIPARKINSON AGENTS; APOMORPHINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; GLUCURONATES; GLUCURONIC ACID; GLUCURONIDASE; HUMANS; HYDROLYSIS; INFUSIONS, INTRAVENOUS; LINEAR MODELS; MALE; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; SULFATASES; SULFATES; TIME FACTORS;

EID: 0031582890     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(97)00370-8     Document Type: Article

References (20)

1. Lees A.J. Fundam. Clin. Pharmacol. 7:1993;121.
2. Gancher S.T., Nutt J.G., Woodward W.R. Mov. Disord. 10:1995;37-43.
3. M. Danhof, J.W. Mandema, A.M. Stijnen, in C.J. van Boxtel, N.H.G. Holford, M. Danhof (Editors), The in vivo Study of Drug Action, Elsevier, Amsterdam, 1992, pp. 31-55.
4. Campbell A., Baldessarini R.J., Teicher M.H., Neumeijer J.L. Neuropharmacology. 24:1985;391.
5. Cannon J.G., Smith R.V., Modiri A., Sood S.P., Borgman R.J., Aleem M.A., Long J.P. J. Med. Chem. 15:1972;273.
6. Colpaert F.L., van Bever W.F., Leijsen J.E. Int. Rev. Neurobiol. 19:1976;225.
7. Kaul P.N., Brochmann-Hanssen E., Leong Way E. J. Pharm. Sci. 50:1961;840.
8. Sam E., Augustijns P., Verbeke N. J. Chromatogr. B. 658:1994;311.
9. Cheng H.-Y., Strope E., Adams R.N. Anal. Chem. 15:1979;2243.
10. Eriksson B.-M., Persson B.-A., Lindberg M. J. Chromatogr. 185:1979;575.
11. Priston M.J., Sewell G.J. J. Chromatogr. B. 681:1996;161.
12. Smith R.V., de Moreno M.R. J. Chromatogr. 274:1983;376.
13. Essink A.W., Lohuis C.P., Klein Elhorst J.T., Rutten W.J. J. Chromatogr. 570:1991;419.
14. Westenrink B.H.C., Horn A.S. Eur. J. Pharmacol. 58:1979;39.
15. Bianchi G., Landi M. J. Chromatogr. 338:1985;230.
16. Yang R.-K., Hsieh J.Y.-K., Kendler K.S., Davis K.L. J. Liq. Chromatogr. 7:1984;191.
17. Smith R.V., Glade J.C., Humphrey D.W. J. Chromatogr. 172:1979;520.
18. Steventon G.B., Williams A.C., Waring R.H., Pall H.S., Adams D. Lancet. 17:1988;644.
19. M. Gibaldi, D. Perrier (Editors), Pharmacokinetics, Marcel Dekker, New York, 1983, pp. 409-417.
20. Smedes F., Kraak J.C., Poppe H. J. Chromatogr. 231:1982;25.